06 October 2020 : Original article
Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations
Youngmin Ko1BCDE, Jee Yeon Kim1BCDE, Sung-Han Kim2ADEF, Dong Hyun Kim1B, Seong Jun Lim1B, Sung Shin1CD, Young Hoon Kim1BCD, Joo Hee Jung1BC, Su-Kil Park3DE, Hyunwook Kwon1ABCDEF*, Duck Jong Han1ADFDOI: 10.12659/AOT.927420
Ann Transplant 2020; 25:e927420
Table 3 Incidence of rejection at 1 year after kidney transplantation.
| Variables | ABOc & HLAc (N=1190) | ABOc & HLAi* (N=131) | ABOi & HLAc (N=358) | ABOi & HLAi* (N=53) | p-Value |
|---|---|---|---|---|---|
| Overall rejection at 1 year | 71 (6.0) | 11 (8.4) | 28 (7.8) | 9 (17.0) | 0.01 |
| ACR only | 46 (3.9) | 3 (2.3) | 12 (3.4) | 1 (1.9) | 0.70 |
| Overall AMR with or without ACR | 25 (2.1) | 8 (6.1) | 16 (4.5) | 8 (15.1) | <0.01 |
| Categorical variables are presented as counts and percentages. ACR – acute cellular rejection; AMR – acute antibody-mediated rejection. * HLA-incompatible kidney transplantation was defined as CDC XM, FCXM-positive, and/or maximal DSA MFI ≥5000. | |||||






